Live Breaking News & Updates on Hillstream Biopharma
Stay updated with breaking news from Hillstream biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hillstream BioPharma, Inc. (NASDAQ:HILS – Free Report) was the target of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 262,000 shares, a decline of 23.6% from the May 31st total of 343,000 shares. Based on an average trading volume of 644,900 shares, the […] ....
Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian Cancers itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Hillstream BioPharma, Inc. announced the signing of an exclusive agreement with Applied Biomedical Science Institute to license technology for human antibodies targeting novel HER2 and HER3. ....
Hillstream BioPharma, Inc. (NASDAQ:HILS – Free Report) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 262,000 shares, a drop of 23.6% from the May 31st total of 343,000 shares. Based on an average trading volume of 644,900 shares, the short-interest ratio is […] ....
Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Rating) saw a significant growth in short interest in May. As of May 31st, there was short interest totalling 343,000 shares, a growth of 30.1% from the May 15th total of 263,600 shares. Based on an average daily volume of 638,000 shares, the days-to-cover ratio is currently 0.5 days. […] ....